Atlas Trials

Real-world Treatment Patterns and Outcomes Among aRCC Patients on Cabozantinib or Axitinib in England

Clinical trial NCT04637204 · COMPLETED

Trial details

NCT number
NCT04637204
Sponsor
Ipsen
Status
COMPLETED
Study type
OBSERVATIONAL
Renal Cell Carcinoma
Start date
2020-11-24
Primary completion
2020-12-11
Enrollment
1540

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.